Abbott clinical biochemical aspartate transaminase (activation) test set
Taiwan·Risk Class 2·FISHER DIAGNOSTICS, A DIVISION OF FISHER SCIENTIFIC COMPANY, LLC, A PART OF THERMO FISHER SCIENTIFIC INC.;; ABBOTT GMBH·Registered Jan 08, 2014 – Jan 08, 2029Active- Analysis ID
- 3d11dd550c31e263049dd654e8aa642d
- Customs Code
- DHA05602584607
- Manufacturer Country
- United States;;Germany
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
- Intended Use
- This product is used in conjunction with the AEROSET system and the ARCHITECT c system (c4000, c8000, c16000) to quantitatively detect aspartate transaminases in human serum or plasma. Performance change: Removed the AEROSET system.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1100 天門冬胺酸轉胺酶試驗系統
- Import Information
- Input;; Contract manufacturing
- Registration Date
- Jan 08, 2014
- Expiry Date
- Jan 08, 2029
Access comprehensive regulatory information for Abbott clinical biochemical aspartate transaminase (activation) test set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3d11dd550c31e263049dd654e8aa642d and manufactured by FISHER DIAGNOSTICS, A DIVISION OF FISHER SCIENTIFIC COMPANY, LLC, A PART OF THERMO FISHER SCIENTIFIC INC.;; ABBOTT GMBH. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.